These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29899783)

  • 61. Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.
    Myers KA; Reeves M; Wei XC; Khan A
    JIMD Rep; 2012; 3():103-6. PubMed ID: 23430881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cerebral computed tomography in maple syrup urine disease.
    Romero FJ; Ibarra B; Rovira M; Natal A; Herrera M; Segarra A
    J Comput Assist Tomogr; 1984 Jun; 8(3):410-1. PubMed ID: 6609940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.
    Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS
    J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis of an intermediate case of maple syrup urine disease: A case report.
    Lin YT; Cai YN; Ting TH; Liu L; Zeng CH; Su L; Peng MZ; Li XZ
    World J Clin Cases; 2023 Feb; 11(5):1077-1085. PubMed ID: 36874425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 68. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
    Schadewaldt P; Wendel U
    Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
    Sowell J; Pollard L; Wood T
    J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exposure to leucine induces oxidative stress in the brain of zebrafish.
    de Medeiros BZ; Wessler LB; Duarte MB; Lemos IS; Candiotto G; Canarim RO; Dos Santos PCL; Torres CA; Scaini G; Rico EP; Generoso JS; Streck EL
    Metab Brain Dis; 2022 Apr; 37(4):1155-1161. PubMed ID: 35275349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
    Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
    Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease.
    Scaini G; Tonon T; Moura de Souza CF; Schuck PF; Ferreira GC; Quevedo J; Neto JS; Amorim T; Camelo JS; Margutti AVB; Hencke Tresbach R; Sperb-Ludwig F; Boy R; de Medeiros PFV; Schwartz IVD; Streck EL
    J Inherit Metab Dis; 2018 May; ():. PubMed ID: 29740775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heterozygous liver transplantation for maple syrup urine disease: First European reported case.
    Roilides I; Xinias I; Mavroudi A; Ioannou H; Savopoulou P; Imvrios G
    Pediatr Transplant; 2016 Sep; 20(6):846-50. PubMed ID: 27357264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.
    Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M
    Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
    Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
    Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuroradiological findings in maple syrup urine disease.
    Indiran V; Gunaseelan RE
    J Pediatr Neurosci; 2013 Jan; 8(1):31-3. PubMed ID: 23772241
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.